Tevogen Inc. (TVGN)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

6.78 on 9 Oct 2026

0 buys3 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$26.28M

Free cash flow

$12.39M

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
13 Mar 2026	Flomenberg Neal See Remarks	Sold at will	$3.21K	0.6%
11 Mar 2026	Flomenberg Neal See Remarks	Sold at will	$3.28K	0.6%
10 Mar 2026	Flomenberg Neal See Remarks	Sold at will	$147.25	0.0%
9 Jun 2025	Saadi Ryan H. Chief Executive Officer	Sold at will	$1.77M	1.2%
12 Mar 2025	Flomenberg Neal See Remarks	Sold at will	$253.94K	6.1%
11 Mar 2025	Flomenberg Neal See Remarks	Sold at will	$73.76K	1.8%

25out of 100

Profitability 25

Financial strength 10

Growth n/a

Insiders 45

Strongest on insiders (45), weakest on financial strength (10). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$6.64K

3 sales

Planned sales

under a 10b5-1 plan